Academic Honors & Events

Search Academic Honors & Events


Top of Their Fields—Annually, Clarivate Analytics and Web of Science release their list of Highly Cited Researchers, which names scientists who rank in the top 1 percent based on citations in their specified field, or across fields. Researchers placed on this list demonstrate significant influence as determined by their peers from around the world. In 2018, four members of the Einstein faculty were noted among the most influential in their fields. They are Paul Frenette, M.D., Ana Maria Cuervo, M.D., Ph.D., Robert Kaplan, Ph.D., and Sylvia Wassertheil-Smoller, Ph.D. Dr. Frenette was named a key researcher in immunology, while Drs. Cuervo, Kaplan and Smoller were acknowledged in a new category termed “cross-field.” Dr. Frenette is chair and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, and is professor of medicine and of cell biology. Dr. Cuervo is co-director of the Einstein Institute for Aging Research, and professor of medicine, of developmental & molecular biology, and of anatomy & structural biology. She also is the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases. Dr. Kaplan is principal investigator of the longitudinal Hispanic Community Health Study/Study of Latinos, as well as professor of epidemiology & population health. He also holds the Dorothy and William Manealoff Foundation and Molly Rosen Chair in Social Medicine. Dr. Wassertheil-Smoller is site principal investigator of the Women’s Health Initiative longitudinal study, as well as distinguished university professor emerita of epidemiology & population health and Dorothy and William Manealoff Foundation and Molly Rosen Chair in Social Medicine Emerita.

Monday, April 01, 2019

Raising Awareness—Ninety-nine percent of cervical cancers are caused by the human papillomavirus (HPV), which is a preventable public health disease. To promote awareness, during cervical cancer awareness month in January, the American Medical Women’s Association (AMWA) teamed with the Global Initiative Against HPV and Cervical Cancer (GIAHC) and Indiana University to hosted the “Us vs. HPV” online webinar series. Reid Mergler, a fourth-year Einstein medical student moderated a session within the series, on HPV and cervical cancer champions. Reid’s goal is to raise awareness about HPV among high school students. She plans to specialize in obstetrics and gynecology, and currently leads the Young Leaders Program for GIAHC and is the national student secretary for AMWA.

Monday, April 01, 2019

Combating Addiction Problems—Aaron Fox, M.D., was elected by the New York Society of Addiction Medicine (NYSAM) to serve on the board of its 2019 conference, which took place in New York City in early February. NYSAM is an organization of physicians from all medical specialties, dedicated to understanding and preventing addiction and to improving addiction treatment. Dr. Fox is director of the Bronx Transitions Clinic, a community health center in the South Bronx that provides medical care to formerly incarcerated individuals. He develops clinical programs to improve access to, and to study the effectiveness of, buprenorphine treatment for opioid use disorder. He also is associate professor of medicine at Einstein and an attending physician in the general internal medicine division at Montefiore.

Thursday, March 21, 2019

Fighting Hepatitis C Epidemic—Governor Andrew Cuomo has appointed Matthew Akiyama, M.D., to serve on the newly formed Hepatitis C Elimination Task Force, whose members will advise how to end the epidemic resulting from this liver disease. Hepatitis C currently affects an estimated 200,000 New Yorkers. The aim of the task force is to stop the spread of Hepatitis C virus by increasing access to medications and expanding programs for connecting New Yorkers in high-risk communities with prevention, screening and treatment services. Governor Cuomo selected task force members whose experience and expertise will develop a strategic plan that improves the quality of life for those living with the virus. Dr. Akiyama is assistant professor of medicine at Einstein, and an attending physician in both general internal medicine and infectious diseases at Montefiore.

Wednesday, January 30, 2019

Hail to the Editor-in-Chief—Peter Dicpinigaitis, M.D., was named editor-in-chief (EIC) of the journal Lung. Since its inception in 1903, Lung, has published peer-reviewed articles, editorials, and reviews on the various issues related to healthy and diseased lungs, and to airways and breathing. An established expert in the field of cough-related research, Dr. Dicpinigaitis established the Montefiore Cough Center, the only such specialty center in New York State and one of the few in the nation that is dedicated to the evaluation and management of patients with chronic cough. His guidelines for cough challenge testing, used to evaluate issues with coughing, have been adopted worldwide. Since 2008, he has served as associate editor of Lung, and he will assume the role of EIC in October 2019. He will be the second Einstein faculty member to hold this position; between the1980s and 1990s, M. Henry Williams, Jr., M.D., former chief of the division of pulmonary medicine at Einstein-Montefiore, served as EIC of Lung. Dr. Dicpinigiatis is professor of medicine at Einstein and site director of critical care medicine at the Weiler Division of Montefiore Medical Center.

Friday, December 28, 2018

Combatting Liver Disease— Fadi-Luc Jaber, Ph.D. has received an Early Career Investigator Award from the American Association for the Study of Liver Diseases (AASLD). Annually, this honor supports 20 early-career researchers worldwide (7 of whom are in the U.S.) to advance innovative liver research done by individuals studying and treating liver disease. As part of the honor, Dr. Jaber  was invited to present his original work on cell therapy at the meeting, which took place in November. Dr. Jaber studies liver regeneration and the use of cell therapy for treating liver diseases. His presentation described how cell transplantation can be improved by enhancing the function of mitochondria and the way the cell resists injury. Dr. Jaber is a research associate in the laboratory of Sanjeev Gupta, M.D., in Einstein’s Marion Bessin Liver Research Center. Dr. Gupta is professor of medicine and of pathology, and the Eleazar & Feige Reicher Chair in Translational Medicine at Einstein. This is the second time that the AASLD has recognized his work with this award.

Tuesday, November 27, 2018

Advancing Aging Research—The Albert Einstein Jack and Pearl Resnick Gerontology Center has awarded Claudene J. George, M.D., its 2018 Resnick Center Emerging Scholarship in Aging. This award recognizes Dr. George’s dedicated work in aging research. Primarily interested in geriatric clinical care and education, her research explores drug interactions, particularly concerning when patients receive multiple drugs to treat an ailment or condition. The Resnick Gerontology Center advances broad aspects of aging research among Einstein clinical investigators and basic scientists, promotes interdepartmental collaborations regarding aging-related endeavors and enhances education and training related to the care of older adults at Einstein hospitals and outpatient clinics. Dr. George is an associate professor of medicine at Einstein, and an attending in the geriatrics division at Montefiore.

Monday, November 19, 2018

Battling the Spread of Lung Cancer—Lung cancer is the most common cause of cancer-related deaths in the United States and worldwide. Despite significant progress in lung cancer advances, it remains difficult to treat when it spreads to the brain. Haiying Cheng, MD, PhD, was recently awarded the 2019 Lori Monroe Scholarship for Lung Cancer Research to advance her investigations into preventing lung cancer-related brain metastasis. This scholarship honors the memory of Lorraine “Lori” Gail Monroe, a registered nurse who co-founded the Lung Cancer Foundation of America and passed away from the disease in 2013. Two researchers are selected internationally every year; each receives a $200,000 grant funded by the foundation in conjunction with the International Association for the Study of Lung Cancer. The fellowships support translational lung cancer research and foster collaboration between basic science researchers and clinical investigators. Dr. Cheng’s group has found a key gene, RICTOR (Rapamycin insensitive companion of mTOR), which plays important roles in the onset of cancer and its progression. With the award funding, she aims to use this gene to further understand how brain metastasis occurs, with a goal of developing an effective treatment to manage and treat lung cancer-related brain metastasis. Dr. Cheng is associate professor of clinical medicine at Einstein and an attending physician in medicine at Montefiore

Monday, November 19, 2018

Hearty Support— Ana Mesquita, Ph.D., has been awarded a two-year fellowship by the American Heart Association (AHA). The honor is among annual fellowships given by the AHA to early career professionals in academia and healthcare, to support research that focuses on cardiovascular disease and function. Dr. Mesquita’s fellowship will support her research project titled, “Regulation of Endosomal Microautophagy by Cellular Stress.” Because autophagy is a pathway used by cells to recycle nutrients and remove unwanted or damaged matter within a cell, Dr. Mesquita and her team will investigate cellular clearance mechanisms (the role of autophagy) in Drosophila melanogaster (fruit fly). This model will help themto identify what might reverse the effect of cellular stress. which is known to contribute to cardiovascular disease. Findings from this project aim to advance methods for preventing heart disease. Dr. Mesquita will conduct her work in the laboratory of Dr. Andreas Jenny, associate professor of developmental and molecular biology and of genetics, where she is a postdoctoral researcher. 

Monday, November 19, 2018

Aiding Mental Health—Parent reflective functioning, or PRF, is an intervention used to help parents in treatment for mental illness with regulating their emotions and preventing relapse of substance abuse. During the annual World Association for Infant Mental Health Congress, held in Rome and hosted by the Italian Association for Infant Mental Health, Amanda Zayde, Psy.D., presented promising new data about enhancing PRF among at-risk parents, drawn from the Mentalization-Based Parenting Program, a pilot study conducted with mothers being treated for mental illness. Dr. Zayde is assistant professor of psychiatry and behavioral sciences at Einstein, and a licensed clinical psychologist in the child outpatient psychiatry department at Montefiore’s Wakefield Division.

Wednesday, September 12, 2018
First Page | Previous Page | Page of 24 | Next Page | Last Page